Suppr超能文献

碘化物对晶状体的保护作用:预防亚硒酸盐诱导的白内障。

Protection by iodide of lens from selenite-induced cataract.

作者信息

Muranov Konstantin, Poliansky Nicolas, Winkler Rudolf, Rieger Gebhard, Schmut Otto, Horwath-Winter Jutta

机构信息

Emanuel Institute of Biochemical Physics RAS, Kosygin Street 4, 117344, Moscow, Russia.

Paracelsus Society for Balneology and Iodine Research, Bad Hall, Austria.

出版信息

Graefes Arch Clin Exp Ophthalmol. 2004 Feb;242(2):146-151. doi: 10.1007/s00417-003-0790-x. Epub 2003 Dec 5.

Abstract

BACKGROUND

Iodide has been used empirically against different age-related eye diseases, including cataract. The purpose of the present study was to investigate the effect of iodide on selenite-induced cataract in rat lens.

METHODS

Young white rats received subcutaneously sodium selenite (20 and 30 nmol/g b.w.) on day 13 post partum (p.p.). Cataract development was measured by expert estimation and image data analysis. Potassium iodide (1.5 nmol/g b.w.) was given (1-5 times) i.p. at different times with respect to the selenite administration. Lens opacification was analyzed in selenite, selenite-iodide, iodide and control groups on day 7 after selenite administration.

RESULTS

Iodide showed a significant protective effect against selenite cataract when injected 2 days (2 times) before selenite injection, i.e., on days 11 and 12 p.p. No significant effects on lens opacity were found: (1) after only one iodide injection (on day 12 p.p.), (2) after an initial iodide administration 1 h before selenite and (3) after injections of iodide once a day for 5 consecutive days. The protective effect of iodide was the same (about 50%) for both selenite doses used.

CONCLUSIONS

There is a time-dependent protective influence of iodide against selenite cataract development. It is supposed that the anticataract effect of iodide could be based on direct or indirect antioxidant mechanisms.

摘要

背景

碘化物已被经验性地用于治疗包括白内障在内的不同年龄相关性眼病。本研究的目的是探讨碘化物对亚硒酸钠诱导的大鼠晶状体白内障的影响。

方法

幼年白色大鼠在产后第13天皮下注射亚硒酸钠(20和30 nmol/g体重)。通过专家评估和图像数据分析来测量白内障的发展。碘化钾(1.5 nmol/g体重)在相对于亚硒酸钠给药的不同时间腹腔注射(1 - 5次)。在亚硒酸钠给药后第7天,对亚硒酸钠组、亚硒酸钠 - 碘化物组、碘化物组和对照组的晶状体混浊情况进行分析。

结果

在亚硒酸钠注射前2天(2次),即产后第11天和第12天注射碘化物时,碘化物对亚硒酸钠诱导的白内障显示出显著的保护作用。未发现对晶状体混浊有显著影响:(1)仅注射一次碘化物后(产后第12天),(2)在亚硒酸钠注射前1小时首次注射碘化物后,以及(3)连续5天每天注射一次碘化物后。对于所使用的两种亚硒酸钠剂量,碘化物的保护作用相同(约50%)。

结论

碘化物对亚硒酸钠诱导的白内障发展具有时间依赖性的保护作用。推测碘化物的抗白内障作用可能基于直接或间接的抗氧化机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验